AU2013344654A1 - Oral transmucosal drug delivery system - Google Patents
Oral transmucosal drug delivery systemInfo
- Publication number
- AU2013344654A1 AU2013344654A1 AU2013344654A AU2013344654A AU2013344654A1 AU 2013344654 A1 AU2013344654 A1 AU 2013344654A1 AU 2013344654 A AU2013344654 A AU 2013344654A AU 2013344654 A AU2013344654 A AU 2013344654A AU 2013344654 A1 AU2013344654 A1 AU 2013344654A1
- Authority
- AU
- Australia
- Prior art keywords
- delivery system
- drug delivery
- oral transmucosal
- transmucosal drug
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drugs Drugs 0.000 title 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2017203861A AU2017203861B2 (en) | 2012-11-14 | 2017-06-07 | Oral Transmucosal Drug Delivery System |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261726475P | 2012-11-14 | 2012-11-14 | |
US61/726,475 | 2012-11-14 | ||
PCT/US2013/070162 WO2014078576A2 (en) | 2012-11-14 | 2013-11-14 | Oral transmucosal drug delivery system |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2017203861A Division AU2017203861B2 (en) | 2012-11-14 | 2017-06-07 | Oral Transmucosal Drug Delivery System |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2013344654A1 true AU2013344654A1 (en) | 2015-05-28 |
AU2013344654B2 AU2013344654B2 (en) | 2017-06-22 |
Family
ID=50728504
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2013344654A Active AU2013344654B2 (en) | 2012-11-14 | 2013-11-14 | Oral transmucosal drug delivery system |
AU2017203861A Active AU2017203861B2 (en) | 2012-11-14 | 2017-06-07 | Oral Transmucosal Drug Delivery System |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2017203861A Active AU2017203861B2 (en) | 2012-11-14 | 2017-06-07 | Oral Transmucosal Drug Delivery System |
Country Status (7)
Country | Link |
---|---|
US (3) | US9352047B2 (en) |
EP (1) | EP2919767B1 (en) |
AU (2) | AU2013344654B2 (en) |
CA (1) | CA2898729C (en) |
ES (1) | ES2802050T3 (en) |
HK (1) | HK1215529A1 (en) |
WO (1) | WO2014078576A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2802050T3 (en) * | 2012-11-14 | 2021-01-15 | Abon Pharmaceuticals Llc | Oral transmucosal drug delivery system |
AR102214A1 (en) * | 2015-10-08 | 2017-02-15 | Amarin Tech S A | A DEVICE FOR THE TRANSDERMAL ADMINISTRATION OF BUPRENORFINA |
WO2018090096A1 (en) * | 2016-11-18 | 2018-05-24 | The University Of Western Australia | Taste masking product |
DE102017104277A1 (en) * | 2017-03-01 | 2018-09-06 | Lts Lohmann Therapie-Systeme Ag | Transmucosal administration system for idebenone |
US11413271B2 (en) * | 2018-06-11 | 2022-08-16 | Abon Pharmaceuticals Llc | Oral eliglustat transmucosal delivery system |
US11813354B1 (en) * | 2019-01-11 | 2023-11-14 | Shear Kershman Laboratories, Inc | Trans-mucosal delivery system for testosterone |
US11485554B2 (en) | 2019-02-22 | 2022-11-01 | Board Of Trustees Of Michigan State University | Methods for extracting and encapsulating phenolics from food waste, related compositions, and related articles |
WO2020243538A1 (en) * | 2019-05-31 | 2020-12-03 | Primo Pharmatech Llc | Unit dosage form for transmucosal drug delivery of an active pharmaceutical ingredient |
CN113952312A (en) * | 2021-10-24 | 2022-01-21 | 重庆市力扬医药开发有限公司 | Silodosin medicine absorbed through oral mucosa |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050180923A1 (en) * | 1997-10-01 | 2005-08-18 | Dugger Harry A.Iii | Buccal, polar and non-polar spray containing testosterone |
IT1298575B1 (en) * | 1998-02-06 | 2000-01-12 | Vectorpharma Int | PHARMACEUTICAL COMPOSITIONS IN THE FORM OF NANOPARTICLES INCLUDING LIPID SUBSTANCES AND ANTIPHILIC SUBSTANCES AND RELATED PROCESS OF |
US6284262B1 (en) * | 1999-01-26 | 2001-09-04 | Virgil A. Place | Compact dosage unit for buccal administration of a pharmacologically active agent |
US6465004B1 (en) * | 1999-06-05 | 2002-10-15 | Noven Pharmaceuticals, Inc. | Solubility enhancement of drugs in transdermal drug delivery systems and methods of use |
ES2299441T3 (en) * | 1999-12-08 | 2008-06-01 | Pharmacia Corporation | SOLID STATE FORM OF CELECOXIB WITH POWERFUL BIODISPONIBILITY. |
US20030091630A1 (en) | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
FR2834897B1 (en) * | 2002-01-23 | 2004-02-27 | Servier Lab | ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF TESTOSTERONE |
ATE452641T1 (en) * | 2002-09-05 | 2010-01-15 | Pantarhei Bioscience Bv | ORAL PHARMACEUTICAL COMPOSITION CONTAINING 15-HYDROXYTESTOSTERONE AND ITS DERIVATIVES |
CA2516816C (en) * | 2003-02-24 | 2012-02-07 | Pharmaceutical Productions, Inc. | Transmucosal drug delivery system |
CA2603649C (en) * | 2005-04-08 | 2014-10-14 | Ozpharma Pty Ltd | Buccal delivery system |
WO2006125642A1 (en) * | 2005-05-27 | 2006-11-30 | Antares Pharma Ipl Ag | Methods and apparatus for transdermal or transmucosal application of testosterone |
MX2007014986A (en) | 2005-06-03 | 2008-02-15 | Duramed Pharmaceuticals Inc | Attachment of a handle to a solid oral dosage form. |
US7908729B2 (en) | 2005-06-03 | 2011-03-22 | Teva Women's Health, Inc. | Method for making a lollipop |
DE102006003512A1 (en) * | 2006-01-24 | 2007-08-02 | Bayer Schering Pharma Ag | Film-forming transmucosal medicament, useful for administering active agents such as androgens, gestagens and estrogens, comprises a film former, which disintegrates in an aqueous medium, and cyclodextrin or its derivatives |
EP1867321A3 (en) * | 2006-06-07 | 2008-11-19 | Familplan Consulting Ltd. | A pharmaceutical product adapted for oral transmucosal administration comprising a pharmaceutical agent |
CN1903056B (en) * | 2006-08-01 | 2010-12-08 | 北京健健康康生物技术有限公司 | Xylitox coffee products for chewing or instant dissolving, and its prepn. method |
US20080131504A1 (en) | 2006-12-01 | 2008-06-05 | Mission Pharmacal Co. | Short Term Slow Release Drug Delivery System |
US20080286340A1 (en) * | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered nicotine containing products |
WO2009027644A2 (en) | 2007-08-24 | 2009-03-05 | Stichting Het Nederlands Kanker Instituut | Composition |
ES2802050T3 (en) * | 2012-11-14 | 2021-01-15 | Abon Pharmaceuticals Llc | Oral transmucosal drug delivery system |
-
2013
- 2013-11-14 ES ES13855604T patent/ES2802050T3/en active Active
- 2013-11-14 US US14/080,505 patent/US9352047B2/en active Active
- 2013-11-14 CA CA2898729A patent/CA2898729C/en active Active
- 2013-11-14 AU AU2013344654A patent/AU2013344654B2/en active Active
- 2013-11-14 WO PCT/US2013/070162 patent/WO2014078576A2/en active Application Filing
- 2013-11-14 EP EP13855604.8A patent/EP2919767B1/en active Active
-
2016
- 2016-03-21 HK HK16103224.4A patent/HK1215529A1/en unknown
- 2016-04-29 US US15/143,059 patent/US9795616B2/en active Active
-
2017
- 2017-06-07 AU AU2017203861A patent/AU2017203861B2/en active Active
- 2017-09-25 US US15/714,347 patent/US10821118B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201502352B (en) | Liposomal drug delivery system | |
EP2906202A4 (en) | Oral drug delivery formulations | |
PL2654864T3 (en) | System for drug delivery | |
GB2491327B (en) | Delayed prolonged drug delivery | |
EP2665503A4 (en) | Medicament delivery device | |
HK1215529A1 (en) | Oral transmucosal drug delivery system | |
AU2013344654A1 (en) | Oral transmucosal drug delivery system | |
EP2804596B8 (en) | Transmucosal administration system for a pharmaceutical drug | |
HUE062316T2 (en) | Drug delivery technology | |
ZA201309156B (en) | Drug delivery system | |
IL227352A0 (en) | Ocular drug delivery system | |
IL236757A0 (en) | Gastro-retentive drug delivery system | |
HK1203802A1 (en) | A drug delivery system | |
HRP20181316T1 (en) | Drug delivery technology | |
GB201210628D0 (en) | Oral medicine dispensing system | |
HK1214522A1 (en) | Oral transmucosal delivery of glatiramer acetate | |
EP2632902A4 (en) | Improved oral targetted drug delivery system | |
GB201110632D0 (en) | Drug delivery formulations | |
GB201018750D0 (en) | Drug delivery system | |
AU2010902059A0 (en) | Novel drug delivery system | |
AU2010904901A0 (en) | Drug delivery device | |
AU2012901190A0 (en) | Liposome Compositions and Systems for Drug Delivery | |
GB201005639D0 (en) | Drug delivery formulations |